Chad J Kolean
First SEC filing: April 15, 2022 · Latest: April 15, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 7, 2026 | CLRB | A | 92,000 | · | · | 92,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 2, 2025 | CLRB | P | 5,000 | $0.01 | $50 | 5,000 Direct | · | Acquired | 17700.0% (price as of 2026-10-02) |
| July 2, 2025 | CLRB | P | 5,000 | $4.99 | $24,950 | 6,418 Direct | +352.61% | Acquired | -64.3% (price as of 2026-10-02) |
| Feb. 14, 2025 | CLRB | A | 290,000 | · | · | 290,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 14, 2024 | CLRB | A | 290,000 | · | · | 290,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 8, 2023 | CLRB | A | 42,554 | · | · | 42,578 Direct | +177308.33% | Acquired | (price as of 2026-10-02) |
| June 23, 2023 | CLRB | A | 104,000 | · | · | 104,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 17, 2023 | CLRB | A | 104,000 | · | · | 104,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 22, 2022 | CLRB | A | 150,000 | · | · | 150,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 18, 2017 | CLRB | A | 80,000 | · | · | 80,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 12, 2016 | CLRB | A | 50,000 | $0.01 | $500 | 52,000 Direct | +2500.00% | Acquired | -94.1% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 7, 2026 | CLRB | Stock option (right to buy) | Common stock | $3.14 | May 28, 2036 | 92,000 | Acquired |
| July 2, 2025 | CLRB | Warrants | Common Stock | $5.25 | July 2, 2030 | 5,000 | Acquired |
| Feb. 14, 2025 | CLRB | Stock option (right to buy) | Common Stock | $0.29 | Feb. 14, 2035 | 290,000 | Acquired |
| June 14, 2024 | CLRB | Stock option (right to buy) | Common Stock | $2.65 | Dec. 15, 2033 | 290,000 | Acquired |
| June 23, 2023 | CLRB | Stock option (right to buy) | Common Stock | $1.68 | Jan. 17, 2033 | 104,000 | Acquired |
| Jan. 17, 2023 | CLRB | Stock option (right to buy) | Common Stock | $1.68 | Jan. 17, 2033 | 104,000 | Acquired |
| Feb. 22, 2022 | CLRB | Stock option (right to buy) | Common Stock | $0.49 | Feb. 22, 2032 | 150,000 | Acquired |
| May 12, 2016 | CLRB | Stock option (right to buy) | Common Stock | $1.48 | May 12, 2026 | 50,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $425,000 | · | · | $713,400 | $85,000 | · | · | $1,223,400 |
| 2023 | $390,000 | · | $112,770 | $284,960 | $234,000 | · | $87,230 | $1,108,960 |
| 2022 | $290,417 | · | · | $58,080 | $113,146 | · | · | $461,643 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.